ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 14.90
-0.40 (-2.61%)
Feb 26, 2026, 5:29 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 52.6 million as of February 26, 2026. Its market cap has decreased by -30.81% in one year.
Market Cap
52.60M
Enterprise Value
6.40M
Revenue
10.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.90
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 52.60M, a decrease of -55.31%. That is a compound annual growth rate of -8.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 54.01M | -3.77% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.85M |
| Spago Nanomedical AB | 82.37M |
| OncoZenge AB | 72.97M |
| Alzinova AB | 66.66M |
| Pila Pharma AB | 54.91M |
| AcouSort AB | 54.18M |
| 2cureX AB | 41.04M |